share_log

Rodman & Renshaw Initiates Coverage On Tharimmune With Buy Rating, Announces Price Target of $17

Rodman & Renshaw Initiates Coverage On Tharimmune With Buy Rating, Announces Price Target of $17

Rodman & Renshaw 對 Tharimmune 進行覆蓋評級,給出買入評級,並宣佈目標價爲17美元。
Benzinga ·  12/07 03:28  · 評級/大行評級

Rodman & Renshaw analyst Elemer Piros initiates coverage on Tharimmune (NASDAQ:THAR) with a Buy rating and announces Price Target of $17.

羅德曼和倫肖分析師埃勒默·皮羅斯開始對Tharimmune(納斯達克股票代碼:THAR)進行報道,評級爲買入,並宣佈目標股價爲17美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論